Literature DB >> 19867162

ON THE OCCURRENCE OF CATALASE IN HUMAN TISSUES AND ITS VARIATIONS IN DISEASES.

M C Winternitz1, C R Meloy.   

Abstract

1. In work along this line it is most important to have a simple method of determining the catalytic activity of tissues. The method must be such that several observations can be made during a single experiment, so that a better idea can be obtained of the velocity of the reaction at various intervals. 2. The catalytic activity of human tissues varies greatly in diseases. A. Nephritis.-The kidney always shows the most marked reduction although the other tissues examined, blood, lung, liver, spleen, likewise show decrease in their power of decomposing hydrogen peroxide. This reduction varies directly with the severity of the pathological lesion in the kidney and the clinical symptoms. The urine also in cases of nephritis shows a much greater inhibiting power than normal urine. This may be accounted for by the reaction of the urine, and subsequent work must prove whether or not the kidney takes any more active part in nephritis and secretes into the blood and urine a substance which manifests itself by a reduction in the catalytic activity. B. The catalytic activity of the blood in the two cases of eclampsia which we have studied was not reduced. This is the most important fact we have so far obtained, if it can be substantiated, since it can furnish us with a ready ante-mortem means of differentiating eclampsia and nephritis. C.Pneumonia.-The lung in the stage of red hepatization has an increased catalytic activity. This increase varies directly with the number of intact red blood cells in the exudate, and in the engorged capillaries. Strength is given to this conclusion by the fact, that on the one hand, there is no increased activity in gray hepatization, while on the other hand, there is an enormously increased activity in the fresh hemorrhagic infarct. D. Tuberculosis.-The decreased activity of the lung in tuberculosis is probably due, for the most part, to the lack of blood in the diseased area, while the lowered activity which is present in the other organs is to be explained by the anaemia and emaciation which accompanies the process. Whether there is a specific catalytic inhibiting substance generated by the process, has not been determined. E. There was no reduction of the catalytic activity in the cases of diabetes mellitus and jaundice studied. F. In the one case of asphyxiation by illuminating gas, there was decided decrease in the catalytic activity of the blood. G. The tissues in the one case of congenital syphilis showed a marked lowering of the catalytic activity. 3. There is a slight decrease in the catalytic activity of the tissues due to post-mortem change, but this is so slight that it is hardly to be taken into consideration in the interpretation of the results obtained. 4. There is no marked change in the catalytic activity due to age. In concluding, we wish to thank Dr. A. S. Loevenhart, at whose suggestion this enzyme was studied, for the unfailing interest with which he has followed the progress of this work, and for the many valuable suggestions he has given us.

Entities:  

Year:  1908        PMID: 19867162      PMCID: PMC2124559          DOI: 10.1084/jem.10.6.759

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells.

Authors:  Christophe Glorieux; Juan Marcelo Sandoval; Nicolas Dejeans; Sandrine Nonckreman; Khadija Bahloula; Hélène A Poirel; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2018-01-28       Impact factor: 6.543

2.  Cubic Liquid Crystalline Nanostructures Involving Catalase and Curcumin: BioSAXS Study and Catalase Peroxidatic Function after Cubosomal Nanoparticle Treatment of Differentiated SH-SY5Y Cells.

Authors:  Miora Rakotoarisoa; Borislav Angelov; Shirly Espinoza; Krishna Khakurel; Thomas Bizien; Angelina Angelova
Journal:  Molecules       Date:  2019-08-22       Impact factor: 4.411

Review 3.  Regulation of Mitochondrial Dynamics in Parkinson's Disease-Is 2-Methoxyestradiol a Missing Piece?

Authors:  Paulina Bastian; Jaroslaw Dulski; Anna Roszmann; Dagmara Jacewicz; Alicja Kuban-Jankowska; Jaroslaw Slawek; Michal Wozniak; Magdalena Gorska-Ponikowska
Journal:  Antioxidants (Basel)       Date:  2021-02-06

Review 4.  The Role of Oxidative Stress in Sarcoidosis.

Authors:  Sara Solveig Fois; Sara Canu; Alessandro Giuseppe Fois
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.